By Editor , 25 September 2026
Autoimmune Treatment Market to Nearly Double to $321.95B by 2034

Pune – September 24, 2026 -- The global autoimmune treatment market reached USD 176.6 billion in 2025 and is forecast to expand at a 6.9% CAGR through 2034, hitting USD 321.95 billion, according to a new analysis from Maximize Market Research.

By Editor , 25 September 2026
MS Treatment Market to Hit $44.45B by 2034 on DMT Demand

Pune, India – September 24, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

By Editor , 25 September 2026
Placenta Market to Hit $275 Billion by 2034 on Cosmetics Boom

Pune, India – September 24, 2026 -- The global placenta market is set to nearly triple from USD 96.1 billion in 2025 to USD 275.18 billion by 2034, expanding at a 12.4% compound annual growth rate, according to a new analysis by Maximize Market Research.

By Editor , 25 September 2026
Bioinformatics Market to Hit $64.60B by 2034 on NGS, AI Demand

Pune – September 24, 2026 -- The global bioinformatics market is projected to expand from $20.34 billion in 2025 to $64.60 billion by 2034, a 13.7% compound annual growth rate, according to new analysis from Maximize Market Research.

By Editor , 25 September 2026
NORD Honors Six Firms for First-of-Kind Rare Disease Therapy Approvals

Norwell, Mass. – September 24, 2026 -- The National Organization for Rare Disorders (NORD) has named six companies and nonprofits as 2026 Industry Innovator honorees for delivering first-of-their-kind FDA-approved therapies to patients with rare diseases that affect a fraction of the more than 30 million Americans living with such conditions.

By Editor , 25 September 2026

San Diego – September 24, 2026 -- ACROBiosystems has launched CHO-Direct, a rapid high-throughput affinity validation service that delivers antibody affinity data in as little as four days from sequence submission, alongside a broader infrastructure platform called ACRO AIx aimed at AI-driven drug discovery (AIDD).

By Editor , 25 September 2026
RS2 Healthcare Partners Takes Stake in Medtech Manufacturer KMM Group

Boston – September 24, 2026 -- RS2 Healthcare Partners has completed an investment in KMM Group, a Hatboro, Pennsylvania-based precision contract manufacturer for the medical device industry, marking the Boston private equity firm's first new platform deal since narrowing its focus exclusively to lower middle-market healthcare investing.

By Editor , 25 September 2026
E Tech Group to Address Lab Automation Compliance Gaps at ISPE Show

West Chester, Ohio – September 24, 2026 -- E Tech Group will present on the compliance and data integrity risks of scaling laboratory automation from pilot to full production at the ISPE Boston Area Chapter 2026 Product Show on October 7 at Gillette Stadium in Foxborough, Massachusetts.

By Editor , 25 September 2026

Shanghai – September 24, 2026 -- Sanyou Biopharmaceuticals Co., Ltd. and NovoCodex Biopharmaceuticals Co., Ltd. have signed a strategic collaboration agreement to jointly develop next-generation antibody-drug conjugates (ADCs), combining Sanyou Bio's AI-driven antibody discovery platforms with NovoCodex's clinically validated site-specific conjugation technology.